Content about McNeil Laboratories

March 31, 2011

Johnson & Johnson on April 4 will install Pat Mutchler as head of the McNeil Consumer Healthcare unit, according to a Wednesday evening Associated Press report.

NEW YORK — Johnson & Johnson on April 4 will install Pat Mutchler as head of the McNeil Consumer Healthcare unit, according to a Wednesday evening Associated Press report.

According to the report, Johnson & Johnson said the changes will allow the company to "give focused attention to quality and compliance, and the critical task of restoring McNeil Consumer Healthcare brands."

March 30, 2011

McNeil Consumer Healthcare on Tuesday recalled one product lot of the analgesic Tylenol 8 Hour extended-release caplets 150-count bottles distributed in the United States, and three brands at the wholesale level.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Tuesday recalled one product lot of the analgesic Tylenol 8 Hour extended-release caplets 150-count bottles distributed in the United States, and three brands at the wholesale level.

“McNeil is taking this action as part of our ongoing surveillance and monitoring efforts that identified a small number of complaints of a musty or moldy odor,” the company stated, specifically referencing only the Tylenol 8 Hour recall. The lot number found on the label on the side of the bottle is ADM074; UPC Code 300450297181.

March 14, 2011

McNeil last week finalized the terms of a consent decree of permanent injunction with the Food and Drug Administration for manufacturing facilities operated by the McNeil Consumer Healthcare Division in Las Piedras, Puerto Rico; Fort Washington, Pa.; and Lancaster, Pa.

FORT WASHINGTON, Pa. — McNeil last week finalized the terms of a consent decree of permanent injunction with the Food and Drug Administration for manufacturing facilities operated by the McNeil Consumer Healthcare Division in Las Piedras, Puerto Rico; Fort Washington, Pa.; and Lancaster, Pa.

The consent decree is subject to approval by the U.S. District Court for the Eastern District of Pennsylvania.

February 18, 2011

NEW BRUNSWICK, N.J. — McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, will extend into the fourth quarter, Johnson and Johnson executives told analysts in January. 


February 18, 2011



McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics to quite a bit of success. For the four weeks ended Dec. 26, 2010, Precise “from the makers of Tylenol” became the No. 3 best-selling heat patch, with $1.9 million in sales across food, drug and mass (excluding Walmart), according to Symphony­IRI Group. And its pain-relieving cream similarly broke in among the top-selling brands — No. 9 with $1.3 million in sales for the four-week period.

January 17, 2011

After announcing its voluntary recall of certain products at a wholesaler level on Friday, Johnson & Johnson's McNeil Consumer Healthcare division provided an update on its internal assessment phase of its comprehensive action plan.

NEW BRUNSWICK, N.J. — After announcing its voluntary recall of certain products at a wholesaler level on Friday, Johnson & Johnson's McNeil Consumer Healthcare division provided an update on its internal assessment phase of its comprehensive action plan.

January 14, 2011

In consultation with the Food and Drug Administration, McNeil Consumer Healthcare on Friday voluntarily recalled certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products, as well as certain lots of Benadryl, Sudafed PE and Sinutab products at the wholesale level.

FORT WASHINGTON, Pa. — In consultation with the Food and Drug Administration, McNeil Consumer Healthcare on Friday voluntarily recalled certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products, as well as certain lots of Benadryl, Sudafed PE and Sinutab products at the wholesale level.

December 17, 2010

Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday announced that it has entered into a definitive agreement to acquire the assets associated with the Dramamine business in the United States from McNeil Consumer Healthcare for $76 million in cash.

“The company expects to quickly and smoothly integrate Dramamine into the Prestige portfolio and drive growth through enhanced brand support,” stated Matthew Mannelly, Prestige Brands CEO.

December 10, 2010

McNeil Consumer Healthcare on Thursday voluntarily recalled all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multisymptom Plus Antigas Softchews distributed in the United States. McNeil is taking this action following some consumer reports of foreign materials in the product, including metal and wood particles.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Thursday voluntarily recalled all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multisymptom Plus Antigas Softchews distributed in the United States. McNeil is taking this action following some consumer reports of foreign materials in the product, including metal and wood particles.

October 18, 2010

McNeil Consumer Healthcare has pulled a lot of Tylenol off the market, following complaints of...

FORT WASHINGTON, Pa. McNeil Consumer Healthcare has pulled a lot of Tylenol off the market, following complaints of a musty odor.

McNeil said the uncharacteristic odor is thought to be caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole. The lot of Tylenol 8-Hour, 50-count bottles are part of lot number BCM155 and carry the following UPC code: 3 0045-0297-51 8.

October 11, 2010

McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics....

NEW YORK McNeil Consumer Healthcare recently parlayed its Tylenol brand franchise into external analgesics.

September 29, 2010

Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of...

WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children's medicines following a nationwide recall.

September 16, 2010

The Emerson Group on Thursday announced the addition of Matthew Poli to the company, effective...

September 15, 2010

House Committee on Oversight and Government Reform chairman Ed Towns, D-N.Y., on Thursday announced that...

WASHINGTON House Committee on Oversight and Government Reform chairman Ed Towns, D-N.Y., on Thursday announced that the committee will hold a hearing Sept. 30 at 10 a.m. to examine the circumstances surrounding Johnson & Johnson’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.

 

August 18, 2010

In an interview with the Wall Street Journal on Wednesday, Johnson & Johnson chairman and...

NEW YORK In an interview with the Wall Street Journal on Wednesday, Johnson & Johnson chairman and CEO William Weldon outlined a number of organizational changes taking place across the company in light of the recent spate of recalled products at McNeil Consumer Healthcare, a J&J company.

First, there is the creation of a corporate oversight group, headed by Ajit Shetty, who will be in charge of operations for the company’s pharmaceuticals, medical device and consumer segments. Shetty will report directly to Weldon.

July 20, 2010

Well-established national brands, or “beacon brands,” are crucial in attracting shoppers to a particular set,...

July 19, 2010

Johnson & Johnson on Tuesday updated its earnings guidance for full-year 2010 to $4.65 to...

July 11, 2010

Regional retail pharmacy chain Kerr Drug has hired former GlaxoSmithKline and Johnson & Johnson executive...

July 8, 2010

McNeil Consumer Healthcare on Thursday issued yet another recall of 21 lots of over-the-counter medicines....

FORT WASHINGTON, Pa. McNeil Consumer Healthcare on Thursday issued yet another recall of 21 lots of over-the-counter medicines. This action is a follow-up to a product recall that McNeil originally announced on Jan. 15, which was initiated following consumer complaints of a musty or moldy odor, which has been linked to the presence of trace amounts of a chemical called 2,4,6-tribromoanisole.

 

June 21, 2010

Rep. Ed Towns, D-N.Y., on Tuesday announced that the House Committee on Oversight and Government...

June 15, 2010

McNeil Consumer Healthcare once again is recalling certain lots of its products as it is...

FORT WASHINGTON, Pa. McNeil Consumer Healthcare once again is recalling certain lots of its products as it is probed by federal investigators for its recall of children’s cough-cold products and manufacturing plant closure.

June 6, 2010

The Committee on Oversight and Government Reform last month opened an investigation into McNeil Consumer...

June 3, 2010

Rep. Ed Towns, D-N.Y., on Thursday announced that the Committee on Government Oversight and Government...

June 2, 2010

In consultation with the Food and Drug Administration, Blacksmith Brands last week voluntarily recalled all...

TARRYTOWN, N.Y. In consultation with the Food and Drug Administration, Blacksmith Brands last week voluntarily recalled all lots of four children's products in the PediaCare line. The products were manufactured for Blacksmith Brands by McNeil Consumer Healthcare at McNeil's Fort Washington, Pa., plant.

 

The four PediaCare items involved in the recall are:

May 31, 2010

McNeil Consumer Healthcare on Tuesday announced the introduction of Visine tired eye relief, which features...